Driven by an awareness of urgent medical needs, GlaxoSmithKline scientists are committed to creating innovative medicines. Thanks to an historic scientific achievement – the sequencing of the human genome – our scientists have at their fingertips a complete dictionary of information to aid them as they probe the mysteries of disease and strive to combat it.

Genetic information enables the discovery of disease-related targets in the body. Until recent years, the number of such targets available to the whole pharmaceutical industry was approximately 500. Today, the search is on for targets numbering in the thousands.